(Q33597031)

28 July 2017

Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease (English)

1 reference

28 July 2017

0 references

1 reference

2

1 reference

28 July 2017

3

Xiongwei Zhu

1 reference

28 July 2017

6

Mark A Smith

1 reference

28 July 2017

1

Massimo Tabaton

1 reference

28 July 2017

5

Gemma Casadesus

1 reference

28 July 2017

4

Hyoung-gon Lee

1 reference

PubMed ID

20019185

28 July 2017

language of work or name

English

0 references

publication date

17 December 2009

1 reference

The American Journal of Pathology

28 July 2017

1 reference

28 July 2017

176

1 reference

28 July 2017

2

1 reference

28 July 2017

540-541

1 reference

Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

Update on the use of memantine in Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

Neuropathology of Alzheimer disease: pathognomonic but not pathogenic

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

Amyloid beta: the alternate hypothesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

21 June 2018

Memantine for dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

Alzheimer's disease: the amyloid cascade hypothesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

Progress in Alzheimer's disease drug discovery: an update.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

Myriad stumbles, Wyeth closes on Alzheimer's.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2808061

10.2353/AJPATH.2010.090856

30 October 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

PubMed ID

20019185